Mike B. Gravenor

Cohort profile: Creation of an E-cohort to Address the Evaluation of Population Secondary Prevention Quality and Outcomes Post-Stroke (ESP-QOPS) in Wales

Exploring epidemic control policies using nonlinear programming and mathematical models

Cardiovascular risk assessment in male and female patients with and without depression: an electronic health record evaluation in Wales

Real-Time Epidemiological Modelling During the COVID-19 Emergency in Wales

Treatment and control of blood pressure in Welsh patients with and without depression: A study of whole-population electronic health records

Investigating the impact of non-pharmaceutical interventions (NPIs) on post-pandemic Respiratory Syncytial Virus (RSV) hospitalisations and seasonality in Wales, UK

Abstract 4365798: Gaps In Risk Factor Management Prior To Major Adverse Events As First Presentation Of Atherosclerotic Cardiovascular Disease

Abstract 4365845: Low Rates Of Escalation Of Lipid Lowering Therapy Amongst Atherosclerotic Cardiovascular Disease Patients With Uncontrolled LDL-C

Treatment and control of low-density lipoprotein cholesterol in patients in Wales: impact of depression

Management of atherosclerotic cardiovascular disease risk in diabetes mellitus patients: a population-level observational cohort study in Wales

Trends in atherosclerotic cardiovascular disease and lipid management: a population-level observational cohort study in Wales

Blood pressure assessment, treatment and control for primary prevention of cardiovascular disease in patients with and without depression

Abstract 4139823: Decline In Treatment, Testing and Control of Lipids Amongst Diabetic Patients, a Population-Level Analysis

Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study

SAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S4-BOW-AF)

Real-time epidemiological modelling during the COVID-19 emergency in Wales

External Validation of HASBLED and ORBIT bleeding risk scores in Wales-AF population

Investigating the Impact of Non-Pharmaceutical Interventions (Npis) on Post-Pandemic Respiratory Syncytial Virus (Rsv) Seasonality and Susceptibility in Wales, UK

Data Mining of Ambulatory Blood Pressure Monitoring

Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales

COVID-19 vaccine uptake and effectiveness in adults aged 50 years and older in Wales UK: a 1.2m population data-linkage cohort approach

Impact of COVID-19 pandemic on community medication dispensing: a national cohort analysis in Wales, UK

Intensity of COVID-19 in care homes following hospital discharge in the early stages of the UK epidemic

Achievement of European Society of Cardiology/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sex

The impact of dementia, frailty and care home characteristics on SARS-CoV-2 incidence in a national cohort of Welsh care home residents during a period of high community prevalence

SARS-CoV-2 infection risk among 77,587 healthcare workers: a national observational longitudinal cohort study in Wales, United Kingdom, April to November 2020

Assessing the impacts of COVID-19 on Care Homes in Wales.

Identifying unmet antithrombotic therapeutic need, and implications for stroke and systemic embolism in atrial fibrillation patients: a population-scale longitudinal study

Risk factors for outbreaks of COVID‐19 in care homes following hospital discharge: A national cohort analysis

Staff–pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach